North America Glucose Monitoring Market Outlook to 2025

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995

GlobalData’s “North America Glucose Monitoring Market Outlook to 2025” is a comprehensive databook report, covering key market data on the North America Glucose Monitoring market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Blood Glucose Meters.

The North America Glucose Monitoring Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2019 company share and distribution share data for Glucose Monitoring Market.
• Global corporate-level profiles of key companies operating within the North America Glucose Monitoring Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Glucose Monitoring Tests is segmented as follows:

• Blood Glucose Meters

Reasons to Buy

Key Reasons to Purchase – The North America Glucose Monitoring Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “North America Glucose Monitoring Market Outlook to 2025” report:
• DexCom Inc
• Abbott Laboratories
• Medtronic Plc

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 6

2 Introduction 8

2.1 What Is This Report About? 8

2.2 Glucose Monitoring Market Segmentation 8

2.3 Definitions of Markets Covered in the Report 9

3 Glucose Monitoring Market, North America 10

3.1 Glucose Monitoring Market, North America, Revenue ($m), 2015-2025 10

3.2 Glucose Monitoring Market, North America, Revenue ($m), 2015-2025 12

3.3 Glucose Monitoring Market, North America, Volume (Units), 2015-2025 14

3.4 Glucose Monitoring Market, North America, Volume (Units), 2015-2025 15

3.5 Glucose Monitoring Market, North America, Company Share by Revenue ($m), 2019 17

4 Glucose Monitoring Market, Canada 18

4.1 Glucose Monitoring Market, Canada, Revenue ($m), 2015-2025 18

4.1.1 Blood Glucose Meters Market, Canada, Revenue ($m), by Segment, 2015-2025 20

4.2 Glucose Monitoring Market, Canada, Volume (Units), 2015-2025 22

4.2.1 Blood Glucose Meters Market, Canada, Volume (Units), by Segment, 2015-2025 24

4.3 Glucose Monitoring Market, Canada, Average Price ($) , 2015-2025 26

4.4 Glucose Monitoring Market, Canada, Distribution Share by Revenue ($m), 2019 27

4.5 Glucose Monitoring Market, Canada, Company Share by Revenue ($m), 2019 28

5 Glucose Monitoring Market, Mexico 29

5.1 Glucose Monitoring Market, Mexico, Revenue ($m), 2015-2025 29

5.1.1 Blood Glucose Meters Market, Mexico, Revenue ($m), by Segment, 2015-2025 31

5.2 Glucose Monitoring Market, Mexico, Volume (Units), 2015-2025 33

5.2.1 Blood Glucose Meters Market, Mexico, Volume (Units), by Segment, 2015-2025 35

5.3 Glucose Monitoring Market, Mexico, Average Price ($) , 2015-2025 37

5.4 Glucose Monitoring Market, Mexico, Distribution Share by Revenue ($m), 2019 38

5.5 Glucose Monitoring Market, Mexico, Company Share by Revenue ($m), 2019 39

6 Glucose Monitoring Market, United States 40

6.1 Glucose Monitoring Market, United States, Revenue ($m), 2015-2025 40

6.1.1 Blood Glucose Meters Market, United States, Revenue ($m), by Segment, 2015-2025 42

6.2 Glucose Monitoring Market, United States, Volume (Units), 2015-2025 44

6.2.1 Blood Glucose Meters Market, United States, Volume (Units), by Segment, 2015-2025 46

6.3 Glucose Monitoring Market, United States, Average Price ($) , 2015-2025 48

6.4 Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), 2019 49

6.5 Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2019 50

7 Overview of Key Companies in North America Glucose Monitoring Market 51

7.1 DexCom Inc 51

7.1.1 Company Overview 51

7.2 Abbott Laboratories 51

7.2.1 Company Overview 51

7.3 Medtronic Plc 51

7.3.1 Company Overview 51

8 Glucose Monitoring Market Pipeline Products 52

9 Recent Developments 58

9.1 Corporate Communications 58

9.1.1 Mar 03, 2020: Ocular Therapeutix Provides update on interim data from the OTX-TKI Phase 1 clinical trial at the Cowen 40th Annual Health Care Conference 58

9.1.2 Feb 26, 2020: Thermo Fisher Scientific President and Chief Executive Officer Marc N. Casper elected Chairman of the Board of Directors 59

9.1.3 Feb 13, 2020: Glooko names Zach Henderson as Chief Commercial Officer and Komathi Stem as Chief Operating Officer 60

9.1.4 Jan 06, 2020: Bio-Rad appoints Dara Grantham Wright Executive Vice President and Clinical Diagnostics Group President 61

9.1.5 Dec 23, 2019: Mayo Clinic names chief digital officer to lead transformative digital strategy, create Center for Digital Health 61

9.1.6 Dec 18, 2019: Senzime recruits general manager to lead US operations 62

9.1.7 Dec 11, 2019: Glooko earns privacy shield certification for policies to safeguard diabetes patient data 62

9.1.8 Dec 05, 2019: Johnson & Johnson names Hubert Joly, Executive Chairman of Best Buy and Mark A. Weinberger, Former EY Global Chairman and CEO to its Board of Directors 63

9.1.9 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform 64

9.1.10 Nov 12, 2019: Liminal BioSciences presents new preclinical data on PBI-4050 65

9.1.11 Nov 04, 2019: Integrity Applications announces the appointment of Allen E. Danzig to its Board of Directors and as Chair of the Nominating, Governance and Compensation Committee 66

9.1.12 Oct 14, 2019: Biocare Medical appoints Nicolas Barthelemy as Executive Chairman 67

9.1.13 Sep 30, 2019: Johnson & Johnson appoints Carlton Lawson to area Managing Director, Consumer, Northern Europe 67

9.1.14 Sep 26, 2019: BD announces leadership succession plan 68

9.1.15 Sep 24, 2019: Jaguar Health to host investor call to provide updates regarding development of Mytesi for the potential follow-on indication of cancer therapy-related diarrhea 69

9.1.16 Sep 05, 2019: Thermo Fisher Scientific elects New Director to Board 70

9.1.17 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 71

9.1.18 Jun 17, 2019: BD announces new leadership for BD Biosciences 71

9.1.19 Jun 05, 2019: Belvarafenib confirms efficacy for solid cancer without approved treatment 72

9.1.20 Jun 04, 2019: Livongo appoints Karen L. Daniel to board of directors to lead audit committee 73

9.1.21 May 28, 2019: LifeScan names Alisandra Rizzolo Head of Transformation 73

9.1.22 May 21, 2019: Glooko appoints Dr. Mark Clements as new Chief Medical Officer 74

9.1.23 May 20, 2019: LifeScan Names Ty Lee Head of Marketing 75

9.1.24 Apr 25, 2019: Aerie Pharmaceuticals announces acceptance of its Investigational New Drug Application for AR-13503 sustained release implant 75

9.1.25 Apr 22, 2019: Bio-Rad Laboratories names Andrew Last as executive vice president and chief operating officer 76

9.1.26 Apr 16, 2019: Ginkgo Bioworks appoints former Bayer CEO Marijn Dekkers as Chairman of its Board of Directors 76

9.1.27 Apr 12, 2019: Basilea reports ceftobiprole (Zevtera) presentations at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 77

9.1.28 Apr 08, 2019: LifeScan names Brian Heald as its new Head of Product 78

9.2 Financial Announcements 79

9.2.1 Feb 13, 2020: Bio-Rad reports fourth-quarter and full-year 2019 financial results 79

9.2.2 Feb 07, 2020: Onkos Surgicals launches magnesium bone scaffolding technology 81

9.2.3 Feb 06, 2020: BD announces results for 2020 first fiscal quarter; lowers fiscal 2020 guidance 83

9.2.4 Jan 30, 2020: Thermo Fisher Scientific reports fourth quarter and full year 2019 results 84

9.2.5 Jan 28, 2020: Beckman Coulter's Access PCT Procalcitonin Assay receives U.S. FDA 510(k) clearance 86

9.2.6 Jan 22, 2020: Johnson & Johnson reports 2019 fourth-quarter and full year results 87

9.2.7 Jan 10, 2020: PQ Bypass announces 100th patient in clinical study to evaluate percutaneous fem-pop bypass for extremely long blockages in leg arteries 88

9.2.8 Nov 26, 2019: Marinomed Biotech AG: Detailed clinical data show rapid onset of action of Budesolv to alleviate hay fever 89

9.2.9 Nov 12, 2019: Senseonics reports third quarter 2019 financial results 92

9.2.10 Nov 06, 2019: Livongo reports third quarter financial results 93

9.2.11 Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance 94

9.2.12 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results 96

9.2.13 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results. 97

9.2.14 Oct 23, 2019: Thermo Fisher Scientific reports third quarter 2019 results 97

9.2.15 Oct 15, 2019: Johnson & Johnson reports 2019 Third-Quarter Results 99

9.2.16 Sep 25, 2019: Katerzia, the first and only amlodipine oral suspension, 1 mg/mL, is now commercially available for pediatric patients 6 years of age and older 100

9.2.17 Sep 05, 2019: Livongo reports second quarter Financial Results 101

9.2.18 Sep 02, 2019: Quantum Genomics Announces Positive FDA Feedback on Phase III Program Design of Firibastat in Resistant Arterial Hypertension 102

9.2.19 Aug 07, 2019: Senseonics Holdings reports second quarter 2019 financial results 103

9.2.20 Aug 06, 2019: BD announces results for 2019 third fiscal quarter; reaffirms fiscal 2019 guidance 104

9.2.21 Aug 01, 2019: Bio-Rad reports second-quarter 2019 financial results 106

9.2.22 Jul 24, 2019: Thermo Fisher Scientific reports second quarter 2019 results 107

9.2.23 Jul 16, 2019: Johnson & Johnson reports 2019 Second-Quarter Results 108

9.2.24 Jul 16, 2019: Senseonics Holdings reports preliminary second quarter 2019 net revenue 109

9.2.25 Jul 16, 2019: Glooko appoints Stephen Lien as new Chief Financial Officer 110

9.2.26 Jul 08, 2019: Concizumab phase 2 data demonstrate its potential as a safe and efficacious subcutaneous prophylaxis treatment for all patients with haemophilia 111

9.2.27 May 22, 2019: Initial study of the minimally invasive RheOx device demonstrates positive results for chronic bronchitis patients 113

9.2.28 May 09, 2019: BD announces results for 2019 second fiscal quarter; updates fiscal 2019 guidance 114

9.2.29 May 09, 2019: Senseonics Holdings reports first quarter 2019 financial results 115

9.2.30 May 08, 2019: Bio-Rad reports first quarter 2019 financial results 116

9.2.31 Apr 29, 2019: Voyager Therapeutics Announces New Data on vectorized antibody program at the American Society of Gene and Cell Therapy 2019 Annual Meeting 118

9.2.32 Apr 24, 2019: Thermo Fisher Scientific announces first quarter 2019 results 121

9.2.33 Apr 16, 2019: Johnson & Johnson reports 2019 first-quarter results 122

9.3 Government and Public Interest 123

9.3.1 May 17, 2019: FDA warns against the use of unauthorized Devices for Diabetes Management 123

9.3.2 Apr 08, 2019: FDA warns about risks of using home use test strips that are pre-owned or not authorized for sale in U.S., including those for glucose, warfarin 125

9.4 Legal And Regulatory 126

9.4.1 Dec 23, 2019: The International Trade Commission issues final decision affirming 10X Genomics infringement of three of Bio-Rad’s Patents 126

9.4.2 Sep 11, 2019: Bio-Rad files new lawsuit against 10X Genomics for Patent Infringement 126

9.4.3 Jul 25, 2019: BD Statement on Georgia facilities 127

9.4.4 Jul 24, 2019: Delaware District Court grants Bio-Rad’s Motion for Permanent Injunction against 10X Genomics 127

9.5 Other Significant Developments 128

9.5.1 Mar 04, 2020: CytoDyn treats first patient with Leronlimab in Phase 2 trial for GvHD under modified trial protocol 128

9.5.2 Feb 04, 2020: Bio-Rad brings FCS express flow cytometry analysis software to ZE5 cell analyzer users 129

9.5.3 Jan 23, 2020: Johnson & Johnson announces $250 million commitment to support Frontline Health Workers, reaching 100 million people by 2030 130

9.5.4 Jan 13, 2020: Healthpeak announces lease with Johnson & Johnson Subsidiary at The Shore at Sierra Point 131

9.5.5 Jan 02, 2020: Agilent expands cross-vendor CDS instrument control 131

9.5.6 Dec 13, 2019: Bio-Rad makes progress recovering from recent ransomware attack 132

9.5.7 Nov 05, 2019: Thermo Fisher Scientific highlights expanded pharma services capabilities during CPhI 132

9.5.8 Oct 23, 2019: AdvaMed Statement on BD Sterilization Plant in Georgia 133

9.5.9 Aug 12, 2019: Diabetes data analysis will lead to improved glucose monitoring and insulin delivery 134

9.5.10 Jul 29, 2019: OBN announce Thermo Fisher Scientific as a new Corporate Sponsor 135

9.5.11 Jun 26, 2019: Livongo integrates with leading smartwatches; delivers personalized health insights to people with chronic conditions 135

9.5.12 Jun 04, 2019: T1D Exchange names Glooko as data management partner in quality improvement collaborative 136

9.5.13 May 16, 2019: AVRA Medical Robotics announces extension of research agreement with University of Central Florida 137

9.5.14 May 15, 2019: Johnson & Johnson outlines strategy to deliver above-market growth at 2019 pharmaceutical business review 138

9.5.15 Apr 30, 2019: Livongo gains approval from Centers for Medicare and Medicare Services as an enrolled provider for Medicare Advantage; empowering America's senior population 139

9.5.16 Apr 30, 2019: Livongo gains approval from Centers for Medicare and Medicaid Services as an enrolled provider for Medicare Advantage; empowering America's senior population 140

9.6 Product News 140

9.6.1 Feb 13, 2020: Endonovo Therapeutics announces collaborating with a Stanford University sponsored Orthopedic Shoulder and Knee Study 140

9.6.2 Oct 08, 2019: Socrates health solutions announces test results: Confirms increased accuracy of technology across range necessary for non-invasive tracking of glucose in real time 141

9.6.3 Jun 10, 2019: Access to continuous glucose monitors in pediatric diabetes populations improves glycemic control, reduces hypoglycemia and improves satisfaction with diabetes care and technology use 142

9.7 Strategy And Business Planning 144

9.7.1 Jan 09, 2020: Livongo diabetes and hypertension solutions now available via Higi smart stations at major retailers 144

9.7.2 Dec 18, 2019: Medtronic acquires digital health startup Klue 145

9.7.3 Nov 13, 2019: Thermo Fisher Scientific opens Customer Solution Center in China to support pharmaceutical and biopharmaceutical laboratories 145

9.7.4 Nov 13, 2019: Thermo Fisher Scientific announces membership of the Pistoia Alliance 146

9.7.5 Nov 12, 2019: XBiotech announces first patient enrolled in placebo-controlled clinical study evaluating its anti-IL-1 therapy Bermekimab in patients with Atopic Dermatitis (Eczema) 146

9.7.6 Oct 18, 2019: Altavant sciences to present data supporting once-daily dosing of Rodatristat Ethyl at CHEST 2019 148

9.7.7 Jul 19, 2019: Midatech announces safety results from first in human study for injectable MidaCore Gold nano particle diabetes vaccine programme – MTX102 148

10 Appendix 151

10.1 Research Methodology 152

10.1.1 Coverage 152

10.1.2 Secondary Research 152

10.1.3 Primary Research 153

10.1.4 Market Modeling and Forecasting 153

10.1.5 Company Share Analysis 155

10.1.6 Distribution Share Analysis 155

10.1.7 Benchmarking 156

10.2 GlobalData Consulting 156

10.3 Contact Us 157

10.4 Disclaimer 157

Table

1.1 List of Tables

Table 1: Glucose Monitoring Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 11

Table 2: Glucose Monitoring Market, North America, Revenue ($m), Historic, USD Constant, 2015-2020 13

Table 3: Glucose Monitoring Market, North America, Revenue ($m), Forecast, USD Constant, 2021-2025 13

Table 4: Glucose Monitoring Market, North America, Volume (Units), 2015-2025 14

Table 5: Glucose Monitoring Market, North America, Volume (Units), 2015-2020 16

Table 6: Glucose Monitoring Market, North America, Volume (Units), 2021-2025 16

Table 7: Glucose Monitoring Market, North America, Company Share by Revenue ($m), USD Constant, 2019 17

Table 8: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, 2015-2020 19

Table 9: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, 2021-2025 19

Table 10: Blood Glucose Meters Market, Canada, Revenue ($m), USD Constant, 2015-2020 21

Table 11: Blood Glucose Meters Market, Canada, Revenue ($m), USD Constant, 2021-2025 21

Table 12: Glucose Monitoring Market, Canada, Volume (Units), 2015-2020 23

Table 13: Glucose Monitoring Market, Canada, Volume (Units), 2021-2025 23

Table 14: Blood Glucose Meters Market, Canada, Volume (Units), 2015-2020 25

Table 15: Blood Glucose Meters Market, Canada, Volume (Units), 2021-2025 25

Table 16: Glucose Monitoring Market, Canada, Average Price ($), 2015-2020 26

Table 17: Glucose Monitoring Market, Canada, Average Price ($), 2021-2025 26

Table 18: Glucose Monitoring Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2019 27

Table 19: Glucose Monitoring Market, Canada, Company Share by Revenue ($m), USD Constant, 2019 28

Table 20: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, 2015-2020 30

Table 21: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, 2021-2025 30

Table 22: Blood Glucose Meters Market, Mexico, Revenue ($m), USD Constant, 2015-2020 32

Table 23: Blood Glucose Meters Market, Mexico, Revenue ($m), USD Constant, 2021-2025 32

Table 24: Glucose Monitoring Market, Mexico, Volume (Units), 2015-2020 34

Table 25: Glucose Monitoring Market, Mexico, Volume (Units), 2021-2025 34

Table 26: Blood Glucose Meters Market, Mexico, Volume (Units), 2015-2020 36

Table 27: Blood Glucose Meters Market, Mexico, Volume (Units), 2021-2025 36

Table 28: Glucose Monitoring Market, Mexico, Average Price ($), 2015-2020 37

Table 29: Glucose Monitoring Market, Mexico, Average Price ($), 2021-2025 37

Table 30: Glucose Monitoring Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2019 38

Table 31: Glucose Monitoring Market, Mexico, Company Share by Revenue ($m), USD Constant, 2019 39

Table 32: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2015-2020 41

Table 33: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2021-2025 41

Table 34: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, 2015-2020 43

Table 35: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, 2021-2025 43

Table 36: Glucose Monitoring Market, United States, Volume (Units), 2015-2020 45

Table 37: Glucose Monitoring Market, United States, Volume (Units), 2021-2025 45

Table 38: Blood Glucose Meters Market, United States, Volume (Units), 2015-2020 47

Table 39: Blood Glucose Meters Market, United States, Volume (Units), 2021-2025 47

Table 40: Glucose Monitoring Market, United States, Average Price ($), 2015-2020 48

Table 41: Glucose Monitoring Market, United States, Average Price ($), 2021-2025 48

Table 42: Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 49

Table 43: Glucose Monitoring Market, United States, Company Share by Revenue ($m), USD Constant, 2019 50

Table 44: Glucose Monitoring Market Pipeline Products 52

Figures

1.2 List of Figures

Figure 1: Glucose Monitoring Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 10

Figure 2: Glucose Monitoring Market, North America, Revenue ($m), Historic, USD Constant, 2015-2025 12

Figure 3: Glucose Monitoring Market, North America, Volume (Units), 2015-2025 14

Figure 4: Glucose Monitoring Market, North America, Volume (Units), 2015-2025 15

Figure 5: Glucose Monitoring Market, North America, Company Share (%) 2019 17

Figure 6: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, 2015-2025 18

Figure 7: Blood Glucose Meters Market, Canada, Revenue ($m), USD Constant, 2015-2025 20

Figure 8: Glucose Monitoring Market, Canada, Volume (Units), 2015-2025 22

Figure 9: Blood Glucose Meters Market, Canada, Volume (Units), 2015-2025 24

Figure 10: Glucose Monitoring Market, Canada, Company Share (%) 2019 28

Figure 11: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, 2015-2025 29

Figure 12: Blood Glucose Meters Market, Mexico, Revenue ($m), USD Constant, 2015-2025 31

Figure 13: Glucose Monitoring Market, Mexico, Volume (Units), 2015-2025 33

Figure 14: Blood Glucose Meters Market, Mexico, Volume (Units), 2015-2025 35

Figure 15: Glucose Monitoring Market, Mexico, Company Share (%) 2019 39

Figure 16: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2015-2025 40

Figure 17: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, 2015-2025 42

Figure 18: Glucose Monitoring Market, United States, Volume (Units), 2015-2025 44

Figure 19: Blood Glucose Meters Market, United States, Volume (Units), 2015-2025 46

Figure 20: Glucose Monitoring Market, United States, Company Share (%) 2019 50

Frequently asked questions

North America Glucose Monitoring Market Outlook to 2025 thematic reports
Currency USD
$5,995

Can be used by individual purchaser only

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Glucose Monitoring Market Outlook to 2025 in real time.

  • Access a live North America Glucose Monitoring Market Outlook to 2025 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.